✦ LIBER ✦
The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
✍ Scribed by Scott Ackler; Michael J. Mitten; Kelly Foster; Anatol Oleksijew; Marion Refici; Stephen K. Tahir; Yu Xiao; Christin Tse; David J. Frost; Stephen W. Fesik; Saul H. Rosenberg; Steven W. Elmore; Alexander R. Shoemaker
- Book ID
- 105993365
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 683 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.